Time-dependent efficacy of combination of silver-containing hydroxyapatite coating and vancomycin on methicillin-resistant Staphylococcus aureus biofilm formation in vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Time-dependent efficacy of combination of silver-containing hydroxyapatite coating and vancomycin on methicillin-resistant Staphylococcus aureus biofilm formation in vitro ; volume:14 ; number:1 ; day:2 ; month:3 ; year:2021 ; pages:1-5 ; date:12.2021
BMC Research Notes / Biomed Central; 14, Heft 1 (2.3.2021), 1-5, 12.2021
- Creator
-
Hashimoto, Akira
Miyamoto, Hiroshi
Kii, Sakumo
Kobatake, Tomoki
Shobuike, Takeo
Noda, Iwao
Sonohata, Motoki
Mawatari, Masaaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-021-05499-7
- URN
-
urn:nbn:de:101:1-2021041621064336889737
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hashimoto, Akira
- Miyamoto, Hiroshi
- Kii, Sakumo
- Kobatake, Tomoki
- Shobuike, Takeo
- Noda, Iwao
- Sonohata, Motoki
- Mawatari, Masaaki
- SpringerLink (Online service)
Other Objects (12)
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Recurrent Challenges for Clinicians: Emergence of Methicillin-resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options
Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri
In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
USA300 Methicillin-resistant Staphylococcus aureus in Cuba
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Recurrent Challenges for Clinicians: Emergence of Methicillin-resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options
Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri
In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
USA300 Methicillin-resistant Staphylococcus aureus in Cuba
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
Vancomycin creep and daptomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Recurrent Challenges for Clinicians: Emergence of Methicillin-resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options
Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri
In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
USA300 Methicillin-resistant Staphylococcus aureus in Cuba
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus